Since the completion of the Human Genome Project and the International HapMap Project, Genome-Wide Association Studies (GWAS) have been undertaken to uncover associations between genetic variants and human diseases and traits. GWAS research is a step forward in biomedical research, and this article provides an overview of the history, study design and significant achievements in this field. In addition, this article presents reliable, core research resources including data repositories, research institutes, consortia, analytical tools and bioethical issues related to GWAS, which can serve as a reference for librarians, graduate students and scientific researchers who are interested in this research area.
Introduction
The Human Genome Project (1990 Project ( -2003 was a groundbreaking international research endeavor sponsored by the National Institutes of Health's (NIH) National Human Genome
Research Institute (NHGRI) and the U.S. Department of Energy that identified and sequenced 2 the human genome and provided the initial foundation for Genome-Wide Association Studies (GWAS). The goals of the Human Genome Project included identifying genes in human DNA in addition to analyzing the ethical, legal, and social issues arising from genomic research (U.S.
Dept. of Energy Genome Program 2011). One of the major achievements of the Human Genome
Project includes mapping over 3 million human single nucleotide polymorphisms (SNPs), or genetic variants, which has given rise to a novel approach to biological research and finding the genetic basis of common, complex diseases.
The completion of the Human Genome Project in 2003 has increased the pace of genomic research and has led to research initiatives such as the International HapMap Project, an international collaboration among scientists in Japan, United Kingdom, Canada, China, Nigeria, and the United States, which identified genetic variants in the human genome across multiple ethnic populations (International HapMap Consortium 2003) . HapMap is short for "haplotype map," where a haplotype is a set of single nucleotide polymorphisms (SNPs), a region of linked common human genetic variants, which serve as markers to locate genes in DNA sequences. The International HapMap Project compared the genetic sequences of different individuals to identify most of the SNPs that occur commonly in the human genome.
These two landmark projects have promoted technologies and resources which have remarkably influenced genomic research in the life sciences. GWAS is one of the approaches in genomic research which investigates genetic factors with high throughput technologies in addition to environmental factors, which explain complex human diseases and traits. GWAS are defined as studies of "genetic variation across the entire human genome that [are] designed to identify genetic associations with observable traits, or the presence or absence of a disease or condition" (NIH 2007) . Specifically, GWAS involves a large number of human subjects 3 consisting of cases and controls whose genomes are genotyped to identify SNPs associated with a specific disease or trait.
Before GWAS, family-based linkage analyses and candidate gene studies were used to investigate the genetic basis of human disease. Linkage analysis is a statistical method to identify chromosomal loci of the genes in which genetic variants are co-inherited with a certain disease or trait within a pedigree. The limitations of linkage analysis were low power and low resolution due to limited family size (Teare and Barrett 2005) . Candidate gene studies involve identifying genetic variants in genes assumed to be associated with a certain disease or trait. The limitation of candidate gene studies is that they overlooked many potential causal regions or genes since they relied on a priori incomplete biological pathways. In addition, these study results tend to be difficult to replicate. Compared to the candidate gene approach, GWAS examines genetic variants across the entire genome, which enables researchers to identify novel genetic variants associated with common diseases and traits. GWAS research is a population-based approach, so it is convenient to collect a large sample which contributes to greater power than family-based linkage analysis, to replicate the findings and to conduct meta-analysis through the sharing of GWAS data.
The following study design has been commonly used to conduct GWAS, and a detailed protocol is available in deBakker et al. (2008) .
 Collecting a large sample of affected and unaffected subjects  Genotyping the SNPs using high through-put technologies  Performing quality control such as minor allele frequency, missing rate, Hardy-Weinberg equilibrium  Imputing ungenotyped SNPs using genotyped SNPs and the HapMap catalog  Performing association tests with a genome-wide p-value cut-off  Finemapping of the locus of significant SNPs to identify variants and genes 4  Replicating the findings in a large, independent sample  Performing meta-analysis using multiple study populations  Performing further analysis of the region to identify the biological mechanism
The first publication of GWAS reported that variation in the gene for complement factor H, which produces a protein involved in regulating inflammation, is associated with age-related macular degeneration (ARMD) (Klein et al. 2005) . This outcome has been one of the most successful GWAS to explain half the risk of ARMD.
In 2007, the Wellcome Trust Case Control Consortium (WTCCC) study published the GWAS results of seven common, complex diseases, including bipolar disorder, coronary artery disease, Crohn's disease, hypertension, rheumatoid arthritis, and Types 1 and 2 diabetes using 14,000 cases and 3,000 common controls from the United Kingdom (WTCCC 2007) . The WTCCC made the GWAS data of these diseases publicly available to other researchers and provided a practical guide for GWAS. The WTCCC study has been frequently cited in GWAS research. After the WTCCC findings, GWAS publications have exponentially increased. Over 3,600 SNPs associated with various human diseases and traits have been discovered as of Spring 2011 (Hindorff et al. 2011) .
A series of these efforts in GWAS research allow us to further understand heritability of human diseases and traits. Diseases that show high proportion of heritability are ARMD, Type 1 diabetes, Crohn's Disease, systemic lupus erythematosus and prostate cancer Kim et al. 2010) . Although GWAS have identified multiple genetic variants associated with certain diseases and traits, their proportion of heritability is relatively low, which is referred to as missing heritability. Type 2 diabetes, HDL cholesterol, height, early onset myocardial infarction, Parkinson's disease and obesity are examples of low heritability. Ku et al. 2010 ). Another limitation is that it can be difficult to distinguish a true association from a false positive result since GWAS scans the entire genome, but this issue has been addressed by using a large sample ranging from 10,000 to 250,000 subjects. Originally, GWAS adopted the common variants, common diseases rationale which resulted in small to moderate effect sizes. In contrast to researchers' expectations, genetic variants associated with human diseases have been identified in gene deserts, which have posed a challenge in finding biological reasoning for their findings.
Genomic research including GWAS has uncovered that complex human diseases are substantially attributed to multiple genetic factors in addition to environmental factors. As the genetic basis of disease is identified through genomic research, these discoveries contribute to the development of personalized medicine, a novel individualized health care approach which takes into account clinical and genomic factors in human diseases. Additional benefits of personalized medicine include prediction, treatment and prevention of disease as well as reduced adverse side effects of medication and treatment. In addition, GWAS have identified the interaction between genetic variants and drug response in order to explain drug metabolism, efficacy and toxicity in pharmacogenomics.
As an extension of the International HapMap Project, the 1000 Genomes Project is the next phase of human genomic research. This project is a collaborative effort among the United States, United Kingdom, China, and Germany to catalog human genome sequence variation across multiple ethnic populations using next-generation sequencing technologies (Durbin et al. 2010 ). Future GWAS research will focus on the study of less common, rare SNPs from the 1000
Genomes Project with next-generation sequencing, which is expected to contribute to solve the missing heritability issue and is a step forward in advancing genomic research. of Choice: Current Reviews for Academic Libraries (Shrode 2010) .
National Institutes of Health Genome-Wide Association Studies (GWAS) Glossary:
http://gwas.nih.gov/09glossary.html This concise glossary with related links is part of the NIH GWAS Policy website, which provides access to GWAS data through the creation of a centralized NIH GWAS data repository.
National Cancer Institute Dictionary of Genetics Terms:
http://www.cancer.gov/cancertopics/genetics-terms-alphalist/a-e The National Cancer Institute Dictionary of Genetic Terms, which is a part of the Dictionary of Cancer Terms, is a reliable government resource and includes more than 100 terms related to genetics. This dictionary was developed by Physician Data Query Cancer Genetics Editorial Board, which consists of 29 specialists in the fields of genetics, clinical oncology, public health, and the social sciences. This dictionary is a useful resource for providing reference service to lower-level undergraduates and general readers. 
Professional Associations and Conferences

Association of Professors of Human and Medical Genetics (APHMG):
http://genetics.faseb.org/genetics/aphmg/aphmg1.htm This repository is accessible through the PubMed interface.
National Human Genome Research Institute Catalog of Published GWAS:
http://www.genome.gov/gwastudies/ The National Human Genome Research Institute Catalog of Published GWAS includes research publications compiled from weekly PubMed literature searches, daily NIH compilations of news and media reports, and the GWAS literature database HuGE Navigator ). The citations chosen for this catalog consist of GWAS publications that assayed at least 100,000 SNPs in the initial stage with the p-value ≤ 1.0 x 10-5. Based on these criteria, this catalog provides detailed information on about 3,600 SNPs for 296 diseases and traits from 750 publications.
NIH database of Genotypes and Phenotypes (dbGaP):
http://www.ncbi.nlm.nih.gov/sites/entrez?db=gap The database of Genotypes and Phenotypes (dbGaP) is a database which archives the 14 results of GWAS investigating the interaction of genotype and phenotype. It was developed by the National Center for Biotechnology Information, a division of the National Library of Medicine, and is accessible through the PubMed interface. SNAP: http://www.broad.mit.edu/mpg/snap/ SNAP is a web-based tool for the rapid retrieval of linkage disequilibrium proxy SNP results given input of one or more query SNPs based on empirical observations from the International HapMap Project and the 1000 Genomes Project (Johnson et al. 2008) . SNAP helps researchers identify, annotate and visualize linkage disequilibrium SNPs, as well as utilize the outcomes for interpretation and comparison of GWAS results and fine-mapping studies.
University of California Santa Cruz (UCSC) Genome Browser:
http://genome.ucsc.edu/index.html
The UCSC Genome Browser developed by the Genome Bioinformatics Group in the Center for Biomolecular Science and Engineering at the University of California Santa Cruz is one of the most comprehensive genomic databases. This browser is a reference database for a large collection of genomes of several species. In particular, this browser provides extensive annotation information collected by annotators worldwide and various tools for visualizing, analyzing and summarizing genomic data.
HuGE Navigator: http://hugenavigator.net HuGE Navigator is a publicly accessible portal that links to information on human genomics and genetic epidemiology. This online resource has been featured in notable journals such as Nature Genetics and cited by the NHGRI GWAS Catalog. 
Analytical Software
Although numerous software packages are used in GWAS, this research guide highlights free software developed through government and/or non-profit organization support. designed to perform multiple types of analyses using large-scale genotype/phenotype with high computational efficiency (Purcell et al. 2007) .
EIGENSOFT: http://helix.nih.gov/Applications/eigensoft.html
The EIGENSOFT package combines functionality from population genetics methods ) and the EIGENSTRAT stratification correction method ).
The EIGENSTRAT method uses principal component analysis to explicitly model ancestry differences between cases and controls along continuous axes of variation. The resulting correction is specific to a candidate marker's variation in frequency across ancestral populations, minimizing spurious associations while maximizing power to detect true associations.
Structure: http://pritch.bsd.uchicago.edu/software/structure2_2.html http://pritch.bsd.uchicago.edu/structure.html Structure, which is a program developed at the University of Chicago, implements a model-based clustering method for inferring population structure using ancestry-informative markers (Pritchard et al. 2000) .
Haploview: http://www.broadinstitute.org/scientific-community/science/programs/medicaland-population-genetics/haploview/haploview Haploview, which was developed at the Broad Institute, is broadly used for linkage disequilibrium (LD) and haplotype block analysis, single SNP and haplotype association test, tagging SNPs, and visualization of PLINK results and HapMap database. The heat map and Manhattan plot are popular applications of Haploview 
Genotyping Technology
Genotyping is the process of determining the genotype of a subject using a research subject's blood or saliva. Genotyping is currently the most costly procedure in GWAS research.
Genotyping technology is mainly provided by commercial technology companies, e.g., Affymetrix http://www.affymetrix.com and Illumina http://www.illumina.com. In GWAS research, the most important factors to consider in choosing pertinent genotyping technology are accuracy, speed, and the cost of processing the assay. foster analysis of broader issues pertaining to genomic research which include the protection of human research subjects, protection from genetic discrimination, the regulation of genetic testing, and fair access to genomic medicine. Legal, regulatory, and public policy aspects of the medical applications of genomic research are also important components of the ELSI Research Program.
Ethical, Legal and Social Issues of Genomic
Genetic Information Nondiscrimination Act (GINA) of 2008:
http://www.genome.gov/24519851
The Genetic Information Nondiscrimination Act (GINA) was passed by Congress in 2008 and is intended to protect people from genetic discrimination by health insurance companies and employers. GINAhelp.org http://www.ginahelp.org/ is an online resource which provides information about GINA and produced by the Genetic Alliance, the Genetics and Public Policy Center at the Johns Hopkins University, and the National Coalition for Health Professional Education in Genetics.
Conclusion
The essential research resources in this GWAS annotated bibliography included online glossaries and dictionaries, professional associations and conferences, research institutes, consortia and projects, genomic research databases, analytical tools and bioethical issues. As GWAS research encompasses the convergence of multiple disciplines including genomics, bioinformatics, statistics, and bioethics, this article provides librarians, graduate students and researchers with valuable information sources and tools needed for the entire GWAS research process.
